CDEK
← All organizations

Hikma

For profitContributed to NME

Also known as: HIKMA | HIKMA FARMACEUTICA | HIKMA INTL PHARMS | Hikma Pharma | Hikma Pharmaceuticals LLC | Hikma Pharmaceuticals USA Inc. | HIKMA PHARMACEUTICALS USA INC | Hikma Pharma,Egypt | HIKMA PHARM CO LTD | HIKMA PHARMS | ribosepharm GmbH

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 1, 2001

First marketed drug

Jan 1, 1978

First NDA

Dec 23, 1980

Last known activity

May 29, 2026

Timeline

1950s

  1. Apr 13, 1956

    promazine hydrochloride— NDA Secondary Org

1970s

  1. Jan 1, 1978

    Hikma— Founded

1980s

  1. Dec 23, 1980

    trilithium citrate— NDA Organization

2010s

  1. Apr 1, 2011

    exemestane— Marketing Organization

  2. May 28, 2014

    Bedford Pharmaceuticals— Acquired

  3. Jun 26, 2018

    West-Ward Pharmaceutical— Acquired

2020s

  1. Sep 27, 2021

    Custopharm Inc— Acquired

Drugs by trial phase (22 distinct, 20 trials)

Phase 4 (2 own, 1 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Other trials (1 own, 3 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (369)

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (15)

Details

Founded
Amman, JO Jan 1, 1978
First NDA
Dec 23, 1980
Last known activity
May 29, 2026